Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lili Qu

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Oncotargets and Therapy|November 26, 2015
miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cellsHaifeng Qin, Jiping Sha, Caixia Jiang, et al.
Oncology Letters|March 20, 2026
RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP-9Jun Luo, Guang Li, Mei Ye, et al.
Journal of Hazardous Materials|April 1, 2023
Selenium in soil-plant system: Transport, detoxification and bioremediationLili Qu, Jiayang Xu, Zhihua Dai, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 23, 2012
[Clinical observation of EGFR-TKI as a first-line therapy on advanced non-small cell lung cancer]Jianjie Li, Lili Qu, Xing Wei, et al.
ACS Chemical Neuroscience|February 11, 2022
Tolcapone Derivative (Tol-D) Inhibits Aβ42 Fibrillogenesis and Ameliorates Aβ42-Induced Cytotoxicity and Cognitive ImpairmentBeibei Chen, Chenye Mou, Fangyan Guo, et al.
Journal of Biomedical Nanotechnology|May 9, 2014
Gene therapy with biosynthetic nanoscale peptide Cecropin A driven by the survivin promoter for hepatocarcinoma cellsLailing Gong, Lili Qu, Zhiyang Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 20, 2025
Mechanisms and therapeutic potential of pharmacological agents targeting inflammasomesHaitao Li, Tiantian Liu, Xuezhen Shi, et al.
Molecular and Cellular Biochemistry|July 1, 2024
Lysosomal cation channel TRPML1 suppression sensitizes acute myeloid leukemia cells to chemotherapeutics by inhibiting autophagyMeifang Dai, Bingqian Lin, Hao Li, et al.
International Journal of Colorectal Disease|April 27, 2011
Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancerQian Bao, Bangshun He, Yuqin Pan, et al.
Nutrition and Cancer|November 26, 2019
TRIM13 inhibits cell migration and invasion in clear-cell renal cell carcinomaHualei Li, Lili Qu, Rui Zhou, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Oncotargets and Therapy|November 26, 2015
miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cellsHaifeng Qin, Jiping Sha, Caixia Jiang, et al.
Oncology Letters|March 20, 2026
RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP-9Jun Luo, Guang Li, Mei Ye, et al.
Journal of Hazardous Materials|April 1, 2023
Selenium in soil-plant system: Transport, detoxification and bioremediationLili Qu, Jiayang Xu, Zhihua Dai, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 23, 2012
[Clinical observation of EGFR-TKI as a first-line therapy on advanced non-small cell lung cancer]Jianjie Li, Lili Qu, Xing Wei, et al.
ACS Chemical Neuroscience|February 11, 2022
Tolcapone Derivative (Tol-D) Inhibits Aβ42 Fibrillogenesis and Ameliorates Aβ42-Induced Cytotoxicity and Cognitive ImpairmentBeibei Chen, Chenye Mou, Fangyan Guo, et al.
Journal of Biomedical Nanotechnology|May 9, 2014
Gene therapy with biosynthetic nanoscale peptide Cecropin A driven by the survivin promoter for hepatocarcinoma cellsLailing Gong, Lili Qu, Zhiyang Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 20, 2025
Mechanisms and therapeutic potential of pharmacological agents targeting inflammasomesHaitao Li, Tiantian Liu, Xuezhen Shi, et al.
Molecular and Cellular Biochemistry|July 1, 2024
Lysosomal cation channel TRPML1 suppression sensitizes acute myeloid leukemia cells to chemotherapeutics by inhibiting autophagyMeifang Dai, Bingqian Lin, Hao Li, et al.
International Journal of Colorectal Disease|April 27, 2011
Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancerQian Bao, Bangshun He, Yuqin Pan, et al.
Nutrition and Cancer|November 26, 2019
TRIM13 inhibits cell migration and invasion in clear-cell renal cell carcinomaHualei Li, Lili Qu, Rui Zhou, et al.
Pageof 11